Cargando…
Prior use of therapeutic anticoagulation does not protect against COVID‐19 related clinical outcomes in hospitalized patients: A propensity score‐matched cohort study
The hypercoagulable state observed in COVID‐19 could be responsible for morbidity and mortality. In this retrospective study we investigated whether therapeutic anticoagulation prior to infection has a beneficial effect in hospitalized COVID‐19 patients. This study included 1154 COVID‐19 patients ad...
Autores principales: | Spiegelenberg, Janneke P., van Gelder, Marleen M. H. J., Maas, Martje L., Hovens, Marcel M. C., Esselink, Anne, Dofferhoff, Anton S. M., Janssen, Rob, van de Maat, Josephine, Janssen, Nico, Blaauw, Marc, Hassing, Robert‐Jan, van Apeldoorn, Marjan, Kerckhoffs, Angèle, Veerman, Karin, Hoogerwerf, Jacobien, Kramers, Cornelis, Leentjens, Jenneke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250934/ https://www.ncbi.nlm.nih.gov/pubmed/33899226 http://dx.doi.org/10.1111/bcp.14877 |
Ejemplares similares
-
Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study
por: Pouw, Niels, et al.
Publicado: (2021) -
Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis
por: Nijman, Gerine, et al.
Publicado: (2021) -
A scoping review protocol on diagnostic strategies to detect occult malignancies in individuals with ischemic stroke
por: Leentjens, Jenneke, et al.
Publicado: (2023) -
Effects of Vitamin D and K on Interleukin-6 in COVID-19
por: Visser, Margot P. J., et al.
Publicado: (2022) -
Corrigendum: Effects of Vitamin D and K on Interleukin-6 in COVID-19
por: Visser, Margot P. J., et al.
Publicado: (2022)